application

ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options

Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate –…

1 day ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

3 days ago

Tower Capital Asia announces majority investment in V-Key – a leader in digital identity and mobile application security

SINGAPORE, Feb. 12, 2026 /PRNewswire/ -- Tower Capital Asia ("TCA") is pleased to announce a strategic majority investment in V-Key…

2 weeks ago

Mitsubishi Electric and Landis+Gyr Accelerate Grid Edge Innovation as Mitsubishi Electric Takes Part in Landis+Gyr’s Application Ecosystem

ATLANTA and TOKYO, Jan. 27, 2026 /PRNewswire/ -- Mitsubishi Electric Corporation and Landis+Gyr (SIX: LAND) announced today that they have…

4 weeks ago

FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…

4 weeks ago

SLK, an Altimetrik Company named Major Contender in Everest Group’s Application Transformation Services for AI-enablement PEAK Matrix Assessment 2025

BANGALORE, India, Dec. 24, 2025 /PRNewswire/ -- SLK, an Altimetrik Company has been recognized as a Major Contender in Everest…

2 months ago

HKUST and SEMI Co-Host Inaugural 2025 Semiconductor Innovation and Intelligent Application Summit (SIIAS)

Uniting Global Semiconductor Leaders to Drive Industry Innovation and GrowthHONG KONG, Dec. 5, 2025 /PRNewswire/ -- The Hong Kong University…

3 months ago

Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…

4 months ago

Alvotech Provides Update on the Status ofU.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

4 months ago

Junshi Biosciences Announces FDAs Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients

SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

4 months ago